Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity.

Journal

Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249

Informations de publication

Date de publication:
23 Apr 2024
Historique:
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 23 4 2024
Statut: aheadofprint

Résumé

Nanotechnology has the potential to provide formulations of antitumor agents with increased selectivity towards cancer tissue thereby decreasing systemic toxicity. This

Identifiants

DOI: 10.1039/d3nr06269d PMID: 38650478
pubmed: 38650478
doi: 10.1039/d3nr06269d
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Nikša Drinković (N)

Polyclinic Drinković, Zagreb, Croatia.

Maja Beus (M)

Institute for Medical Research and Occupational Health, Zagreb, Croatia. ivinkovic@imi.hr.
ORCID: 0000-0002-9619-7156

Rinea Barbir (R)

Institute for Medical Research and Occupational Health, Zagreb, Croatia. ivinkovic@imi.hr.

Željko Debeljak (Ž)

JJ Strossmayer University of Osijek, Faculty of Medicine, Osijek, Croatia.
University Hospital Osijek, Osijek, Croatia.
ORCID: 0000-0002-1789-5387

Blanka Tariba Lovaković (B)

Institute for Medical Research and Occupational Health, Zagreb, Croatia. ivinkovic@imi.hr.
ORCID: 0000-0001-5908-506X

Nikolina Kalčec (N)

Institute for Medical Research and Occupational Health, Zagreb, Croatia. ivinkovic@imi.hr.

Marija Ćurlin (M)

Croatian Catholic University, Zagreb, Croatia.

Ana Bekavac (A)

University of Zagreb, School of Medicine, Zagreb, Croatia.
ORCID: 0000-0002-5804-0609

Dunja Gorup (D)

Department of Neuroradiology, Klinik für Neuroradiology, Universitätspital Zürich Universitätsspital Zürich, 8006 Zürich, Switzerland.

Ivan Mamić (I)

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.

Dario Mandić (D)

University Hospital Osijek, Osijek, Croatia.

Vedran Micek (V)

Institute for Medical Research and Occupational Health, Zagreb, Croatia. ivinkovic@imi.hr.

Petra Turčić (P)

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
ORCID: 0000-0002-2621-8257

Nazende Günday-Türeli (N)

MyBiotech GmbH, Überherrn, Germany.
ORCID: 0000-0002-6310-4785

Emre Türeli (E)

MyBiotech GmbH, Überherrn, Germany.

Ivana Vinković Vrček (I)

Institute for Medical Research and Occupational Health, Zagreb, Croatia. ivinkovic@imi.hr.
University of Rijeka, Faculty of Medicine, Rijeka, Croatia.
ORCID: 0000-0003-1382-5581

Classifications MeSH